Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,549 active trials61 approved drugs295 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,963)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02145494 | The SPARC Trial: Stereotactic Prostate Ablative Radiotherapy Using Cyberknife(SPARC) | unknown | Phase 2 | 20 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 23, 2014 | clinicaltrials |
| NCT01711268 | Sunitinib Drug Levels and Outcomes in Kidney Cancer(CRESTO) | unknown | — | 35 | Western Sydney Local Health DistrictOTHER | 1 | May 15, 2014 |
| clinicaltrials |
| NCT02138760 | Comparison of MRI Fusion Biopsy Techniques in Men With Elevated PSA and Prior Negative Prostate Biopsy | unknown | N/A | 400 | Kaiser PermanenteOTHER | 1 | May 15, 2014 | clinicaltrials |
| NCT02132988 | Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer | unknown | Phase 2 | 110 | Mackay Memorial HospitalOTHER | 1 | May 7, 2014 | clinicaltrials |
| NCT01381822 | Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors(TH-CR-410) | unknown | Phase 1 | 58 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 21, 2014 | clinicaltrials |
| NCT02103933 | Pilot Study to Evaluate the Knowledge and Understanding on Surgery for Patients With Hysterectomy | unknown | — | 200 | National Cancer Center, KoreaOTHER_GOV | 0 | Apr 4, 2014 | clinicaltrials |
| NCT00175396 | Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy | unknown | Phase 3 | 400 | University of British ColumbiaOTHER | 1 | Mar 17, 2014 | clinicaltrials |
| NCT01577784 | Pazopanib in Second-line Therapy in Renal Cell Carcinoma | unknown | Phase 2 | 27 | Associació per a la Recerca Oncologica, SpainOTHER | 1 | Mar 12, 2014 | clinicaltrials |
| NCT02083614 | The Effect of Clamping the Indwelling Urethral Catheter Before Removal From Patients After Type III Radical Hysterectomy | unknown | N/A | 200 | First Affiliated Hospital of Chongqing Medical UniversityOTHER | 1 | Mar 11, 2014 | clinicaltrials |
| NCT02074189 | Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer | unknown | Phase 3 | 200 | Southwest Hospital, ChinaOTHER | 1 | Feb 28, 2014 | clinicaltrials |
| NCT02074241 | Molecular Markers of Chemosensitivity for Bladder Cancer | unknown | — | 200 | Southwest Hospital, ChinaOTHER | 1 | Feb 28, 2014 | clinicaltrials |
| NCT02073110 | Optical Biopsy to Improve the Diagnosis of Kidney Cancer | unknown | — | 194 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Feb 27, 2014 | clinicaltrials |
| NCT02070952 | CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer | unknown | N/A | 167 | Riverside Community Hospital, CaliforniaOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT01334437 | Blood Test for Ovarian Cancer Associated Auto Antibodies | unknown | — | 250 | Eventus Diagnostics LtdINDUSTRY | 1 | Feb 20, 2014 | clinicaltrials |
| NCT00295802 | Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer | unknown | Phase 2 / Phase 3 | 141 | EDAP TMS S.A.INDUSTRY | 2 | Feb 7, 2014 | clinicaltrials |
| NCT01755585 | Irradiation Modulates the Pharmacokinetics of Anticancer Drugs | unknown | — | 40 | Far Eastern Memorial HospitalOTHER | 0 | Jan 22, 2014 | clinicaltrials |
| NCT02041559 | The Effect of Different Doses of Remifentanil on Kidney Function During Robot Assisted Prostatectomy - A Retrospective Study | unknown | — | 1,500 | Yonsei UniversityOTHER | 1 | Jan 22, 2014 | clinicaltrials |
| NCT02037464 | CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer(CAPSAICIN) | unknown | Phase 2 | 100 | Sunnybrook Health Sciences CentreOTHER | 1 | Jan 16, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00301990 | Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | 65 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00553124 | Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer | unknown | Phase 3 | 3,400 | University Hospital BirminghamOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00553215 | Quality of Life in Patients With Bladder Cancer | unknown | — | 2,700 | University of BirminghamOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00553345 | Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer | unknown | Phase 3 | 515 | University of BirminghamOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00553566 | Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer | unknown | — | 1,600 | University of BirminghamOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00717587 | Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer | unknown | Phase 2 | 20 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00967954 | Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer | unknown | N/A | 120 | Cancer Research UKOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00002775 | Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 1 / Phase 2 | 37 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00003064 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer | unknown | Phase 1 / Phase 2 | 30 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00003560 | Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | unknown | Phase 2 | 40 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00003718 | Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma | unknown | Phase 2 | 25 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00030888 | UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer | unknown | Phase 2 | — | University of California, San FranciscoOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00295997 | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia | unknown | N/A | 35 | University of California, San FranciscoOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00002846 | Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer | unknown | Phase 2 | 14 | Blumenthal Cancer Center at Carolinas Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00002847 | Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | 14 | Blumenthal Cancer Center at Carolinas Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003633 | Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | unknown | Phase 1 | 12 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003717 | Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 2 | 17 | St. Barnabas Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00024063 | SU006668 in Treating Patients With Advanced Solid Tumors | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00080977 | High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2 | unknown | Phase 2 | — | Blumenthal Cancer Center at Carolinas Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00093522 | Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer | unknown | Phase 2 | 28 | St. Luke's Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00002477 | Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer | unknown | Phase 3 | — | Medical Research CouncilOTHER_GOV | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00002589 | Lymphocyte Therapy in Treating Patients With Kidney Cancer | unknown | Phase 2 | 90 | National Cancer Institute (NCI)NIH | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00021385 | Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer | unknown | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00045123 | R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence | unknown | Phase 2 | — | Myrexis Inc.INDUSTRY | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00054626 | Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer | unknown | Phase 3 | 700 | Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, ItalyOTHER_GOV | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00684970 | Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)(TLH-202) | unknown | Phase 2 | 100 | Tiltan Pharma Ltd.INDUSTRY | 1 | Dec 5, 2013 | clinicaltrials |
| NCT01938339 | Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer | unknown | N/A | 60 | Seoul National University HospitalOTHER | 1 | Dec 5, 2013 | clinicaltrials |
| NCT00003181 | Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | 35 | Hope Cancer Institute, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00003183 | Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 1 / Phase 2 | 64 | Hope Cancer Institute, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005958 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer | unknown | Phase 2 | — | AmgenINDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005960 | Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | unknown | Phase 2 | — | AmgenINDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
Data updated 23 days agoSource updated May 23, 2014source: clinicaltrials